JohnLewisLeahyMD

Endocrinology • South Burlington, VT

Diabetes, Lipid Metabolism

Physician

Join to view full profile

Dr. Leahy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Leahy's full profile

Already have an account?

Office
62 Tilley Drive
South Burlington, VT 05403
Phone+1 802-847-4576

Education & Training

Virginia Commonwealth University Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 1981 - 1984
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1977 - 1980
Virginia Commonwealth University School of MedicineClass of 1977

Certifications & Licensure

VT State Medical License 1996 - 2024
VA State Medical License 1978 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Elected Member The American Society for Clinical Investigation, 1995

Publications & Presentations

PubMed

6 citations
SetD7 (Set7/9) is a novel target of PPARγ that promotes the adaptive pancreatic β-cell glycemic response.
Thomas L. Jetton, Patricio Flores-Bringas, John L. Leahy, Dhananjay Gupta
The Journal of Biological Chemistry. 2021-09-27
18 citations
Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations.
John Jack Leahy, Grazia Aleppo, Vivian Fonseca, Satish K. Garg, Irl B. Hirsch
Journal of the Endocrine Society. 2019-10-01
Sodium-Glucose Cotransporter 2 Inhibitor Protection Against Adverse Cardiovascular and Renal Outcomes in Patients With Type 2 Diabetes.
Edward Shahady, John L. Leahy
Clinical Diabetes. 2019-07-01

Lectures

Updates in Individualizing Therapy in Type 2 Diabetes: Optimizing Insulin and Non-Insulin Combinations
ENDO 2019 - New Orleans, LA - 3/24/2019
Designing a Treatment Plan for Patients with T2DM (Including CV Outcomes Considerations)
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/18/2018
Transition from Beta-Cell Compensation to ER Stress in Long-term Fat Fed Mice
Colchester, VT - 6/13/2014

Press Mentions

Diabetes Advances Poised to Help Manage Blood Sugar After MealsOctober 7th, 2019